Detection of familial defective apoB (FDB) mutations in hypercholesterolemic children and adolescents by denaturing high performance liquid chromatography (DHPLC)

Clinical Biochemistry

Volumn 41, Issue 6, 2008, Pages 395-399

  Nelken, Joanna ^a   Meshkani, Reza ^a   Chahal, Nita ^a   McCrindle, Brian ^a   Adeli, Khosrow ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Apolipoprotein B; Denaturing HPLC; Familial defective apoB; Hypercholesterolemia; Mutation

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B100; ARGININE; CHOLESTEROL; GLUTAMINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NUCLEOTIDE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; AUTOMATION; CHILD; CODON; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADOLESCENT; AMINO ACID SEQUENCE; APOLIPOPROTEINS B; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; HUMANS; HYPERCHOLESTEROLEMIA; MOLECULAR SEQUENCE DATA; POINT MUTATION;

EID: 40849101621     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.12.018     Document Type: Article

References (30)

1. American Academy of Pediatrics. National Cholesterol Education Program: report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 89 3 Pt 2 (1992) 525-584
2. American Academy of Pediatrics. Committee on Nutrition: statement on cholesterol. Pediatrics 90 3 (1992) 469-473
3. Huang L.S., Miller D.A., Bruns G.A.P., and Breslow J.L. Mapping of the human APOB gene to chromosome 2p and demonstration of a two-allele restriction fragment length polymorphism. Proc Natl Acad Sci 83 3 (1986) 644-648
4. Brown M.S., and Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 232 4746 (1986) 34-47
5. Knott T.J., Pease R.J., Powell L.M., Wallis S.C., Rall Jr. S.C., Innerarity T.L., et al. Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature 323 6090 (1986) 734-738
6. Innerarity T.L., Mahley R.W., Weisgraber K.H., Bersot T.P., Krauss R.M., Vega G.L., et al. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res 31 8 (1990) 1337-1349
7. Pullinger C.R., Hennessy L.K., Chatterton J.E., Liu W., Love J.A., Mendel C.M., et al. Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest 95 3 (1995) 1225-1234
8. Gaffney D., Reid J.M., Cameron I.M., Vass K., Caslake M.J., Shepherd J., et al. Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia. Arterioscler Thromb Vasc Biol 15 8 (1995) 1025-1029
9. Gross E., Arnold N., Goette J., Schwarz-boeger U., and Kiechle M. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Human Genet 105 1-2 (1999) 72-78
10. Gross E., Arnold N., Pfeifer K., Bandick, and Kiechle M. Identification of specific BRCA1 and BRCA2 variants by DHPLC. Hum Mutat 16 4 (2000) 345-353
11. Jones A.C., Austin J., Hansen N., Hoogendoorn B., Oefner P., Cheade J.P., et al. Optimal temperature selection for mutation detection by denaturing high performance liquid chromatography and comparison to SSCP and heteroduplex analysis. Clin Chem 45 8 Pt 1 (1999) 1133-1140
12. Soria L.F., Ludwig E.H., Clarke H.R., Vega G.L., Grudny S.M., and McCarthy B.J. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci USA 86 2 (1989) 587-591
13. Innerarity T.L., Mahley R.W., Weisgraber K.H., et al. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res 31 (1990) 1337-1349
14. Tybjaerg-Hansen A., and Humphries S. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease. Atherosclerosis 96 (1992) 91-107
15. Myant N.B. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolemia. Atherosclerosis 104 (1993) 1-18
16. Leren T.P., Rodningen O.K., Tonstad S., et al. Identification of the apo B-3500 mutation in the Norwegian population. Scand J Clin Lab Invest 55 (1995) 217-221
17. Tybjaerg-Hansen A., Steffensen R., Meinertz H., et al. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. N Engl J Med 338 (1998) 1577-1584
18. Brousseau T., Arveiller D., Cambou J.P., et al. Familial defective apolipoprotein B-100 and myocardial infarction: The ECTIM study. Atherosclerosis 116 (1995) 269-271
19. Rabes J.P., Varret M., Saint-Jore B., et al. Familial ligand-defective apolipoprotein B-100: simultaneous detection of the Arg3500Gln and Arg3531Cys mutations in a French population. Hum Mutat 10 (1997) 160-163
20. Miserez A.R., Laager R., Chiodetti N., et al. High prevalence of familial defective apolipoprotein B-100 in Switzerland. J Lipid Res 35 (1994) 574-583
21. Tybjaerg-Hansen A., and Humphries S. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease. Atherosclerosis 96 (1992) 91-107
22. Hansen P.S. Familial defective apolipoprotein B-100. Dan Med Bull 45 (1998) 370-382
23. Hansen P.S., Norgaard-Petersen B., Meinertz H., et al. Incidence of the apolipoprotein B-3500 mutation in Denmark. Clin Chim Acta 230 (1994) 101-104
24. Viola S., Benlian P., Morali A., Sobbelaere D., Lacaille F., Rieu D., Ginies J.L., et al. Apolipoprotein B Arg3500Gln mutation prevalence in children with hypercholesterolemia: a French multicenter study. J Pediatr Gastroenterol Nutr 33 (2001) 122-126
25. Myant N.B. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolemia. Atherosclerosis 104 (1993) 1-18
26. Dedoussis G.V.Z., Schmidt H., and Genschel J. LDL-receptor mutations in Europe. Human Mutat 24 6 (2004) 443-459
27. Xiao W., and Oefner P.J. Denaturing high-performance liquid chromatography: a review. Hum Mut 17 (2001) 439-474
28. Cotton R.G.H. Mutation detection 2001: novel technologies, developments and applications for analysis of the human genome. Hum Mut 19 (2002) 313-314
29. Pan K.F., Liu W., Lu Y.Y., Zhang L., Li Z.P., Lu W.L., et al. High throughput detection of microsatellite instability by denaturing high-performance liquid chromatography. Hum Mut 22 (2003) 388-394
30. Meriño-Ibarra E., Castillo S., Mozas P., Cenarro A., Martorell E., Díaz J.L., et al. Screening of APOB gene mutations in subjects with clinical diagnosis of familial hypercholesterolemia. Hum Biol 77 5 (2005) 663-673